Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

STIM

Neuronetics Inc

May 01 • 11:05AM ET

3.59

Dollar change +0.22
Percentage change 6.63	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC DFAS AVSC DFAC

Index	-	P/E	-	EPS (ttm)	-1.06	Insider Own	10.42%	Shs Outstand	29.09M	Perf Week	-4.18%
Market Cap	106.94M	Forward P/E	-	EPS next Y	-0.64	Insider Trans	-7.06%	Shs Float	26.66M	Perf Month	-20.85%
Income	-30.19M	PEG	-	EPS next Q	-0.31	Inst Own	61.81%	Short Float	0.22%	Perf Quarter	5.69%
Sales	71.35M	P/S	1.50	EPS this Y	11.87%	Inst Trans	-1.98%	Short Ratio	0.35	Perf Half Y	232.72%
Book/sh	1.18	P/B	3.06	EPS next Y	31.11%	ROA	-25.95%	Short Interest	0.06M	Perf Year	56.23%
Cash/sh	2.04	P/C	1.77	EPS next 5Y	-	ROE	-66.17%	52W Range	1.03 - 5.07	Perf YTD	23.91%
Dividend Est.	-	P/FCF	-	EPS past 5Y	17.12%	ROI	-31.51%	52W High	-29.12%	Beta	2.50
Dividend TTM	-	Quick Ratio	4.33	Sales past 5Y	7.39%	Gross Margin	69.66%	52W Low	248.87%	ATR (14)	0.28
Dividend Ex-Date	-	Current Ratio	4.73	EPS Y/Y TTM	23.59%	Oper. Margin	-42.82%	RSI (14)	41.29	Volatility	6.28% 7.18%
Employees	203	Debt/Eq	1.83	Sales Y/Y TTM	9.42%	Profit Margin	-42.31%	Recom	1.50	Target Price	7.00
Option/Short	Yes / Yes	LT Debt/Eq	1.80	EPS Q/Q	39.25%	Payout	-	Rel Volume	0.34	Prev Close	3.37
Sales Surprise	2.33%	EPS Surprise	26.75%	Sales Q/Q	11.63%	Earnings	May 07 BMO	Avg Volume	165.81K	Price	3.59
SMA20	-9.02%	SMA50	-8.01%	SMA200	45.73%	Trades		Volume	16,019	Change	6.63%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

Today 08:31AM	NeuroStar TMS Advances Treatment for Adolescents During Mental Health Awareness Month (GlobeNewswire) +6.63%
Apr-23-24 04:30PM	Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-10-24 08:31AM	New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital (GlobeNewswire)
Apr-01-24 10:52AM	Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression (Zacks)
Mar-27-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
01:10AM	Loading…
01:10AM	Neuronetics wins FDA clearance for device to treat adolescents with depression (MedTech Dive)
Mar-25-24 08:30AM	NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression (GlobeNewswire) +11.35%
Mar-08-24 08:06AM	Neuronetics (STIM) Progresses in MRD and TRD With New Deal (Zacks)
Mar-07-24 02:00PM	Neuronetics Inc (STIM) Reports Record Revenues in Q4 and Full Year 2023 (GuruFocus.com)
10:16AM	Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:22AM	Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network (GlobeNewswire)
Mar-05-24 11:39PM	Q4 2023 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +15.41%
08:40AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:46AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results (GlobeNewswire)
08:30AM	Loading…
Feb-20-24 08:30AM	Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-12-24 08:32AM	Neuronetics Launches Latest Evolution in its TrakStar Patient Data Management System (GlobeNewswire)
Feb-06-24 08:28AM	NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update (GlobeNewswire) +6.67%
Jan-08-24 08:30AM	Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire) -6.35%
Dec-18-23 08:49AM	Neuronetics Receives 510(k) Clearance for NeuroSite Coil Placement Accessory (GlobeNewswire)
Dec-04-23 08:56AM	NeuroStar TMS Receives Expanded Regulatory Approval in Japan (GlobeNewswire) +8.87%
Nov-15-23 04:15PM	Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:57AM	NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements (GlobeNewswire)
Nov-09-23 08:32AM	Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage (GlobeNewswire) -11.30%
Nov-08-23 01:16PM	Neuronetics, Inc. (NASDAQ:STIM) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 07:57AM	Neuronetics Inc (STIM) Reports 8% Revenue Growth in Q3 2023 (GuruFocus.com) +8.11%
07:43AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
Nov-06-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.50%
Oct-24-23 08:30AM	Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
08:56AM	Loading…
Oct-16-23 08:56AM	Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes (GlobeNewswire)
Oct-03-23 09:21AM	Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility (GlobeNewswire) -6.87%
Sep-12-23 08:56AM	In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression (GlobeNewswire)
Aug-21-23 08:56AM	NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards (GlobeNewswire)
Aug-18-23 09:02PM	Cannell Capital LLC Reduces Stake in Neuronetics Inc (GuruFocus.com)
Aug-14-23 09:02AM	Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform (GlobeNewswire)
Aug-11-23 12:00PM	Neuronetics (STIM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Aug-08-23 08:22AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results (GlobeNewswire)
Aug-04-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-25-23 08:30AM	Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Jul-19-23 08:56AM	Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans (GlobeNewswire)
Jul-17-23 08:46AM	NeuroStar Achieves Milestone Regulatory Clearance in South Korea (GlobeNewswire)
Jul-11-23 08:56AM	NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player (GlobeNewswire)
Jun-12-23 11:25AM	Abbott (ABT) EPD Sales Gain Traction, Margin Pressure Lingers (Zacks)
11:18AM	LabCorp (LH) Gives Update as Fortrea Spinoff Nears Closure (Zacks)
08:59AM	Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy (GlobeNewswire)
Jun-09-23 09:50AM	Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger (Zacks)
08:53AM	Charles River (CRL) to Aid INADcure in Plasmid DNA Manufacture (Zacks)
Jun-08-23 12:18PM	Neuronetics, Inc. (NASDAQ:STIM) Could Be Riskier Than It Looks (Simply Wall St.)
09:31AM	Bruker (BRKR) Launches timsTOF Ultra Mass Spec and VistaScan (Zacks)
Jun-06-23 11:19AM	Quest Diagnostics' (DGX) Contract Wins Aid Amid Volume Woes (Zacks)
08:04AM	Bruker's (BRKR) Latest Workflows to Aid Applied Markets (Zacks)
Jun-02-23 10:26AM	Walgreens Boots (WBA) Gains From New Alliances Amid Macro Woes (Zacks)
08:33AM	Neogen (NEOG) Introduces 2 Assays for Histamine Detection (Zacks)
Jun-01-23 08:39AM	LabCorp (LH) Expands Precision Oncology With Biopsy Test (Zacks)
May-31-23 09:16AM	Illumina (ILMN) to Present Real-World CGP Data at ASCO Meet '23 (Zacks)
May-30-23 01:50PM	Neuronetics investing in NeuroStar awareness as drug-free treatment alternative for depression (News Direct) -5.14%
May-29-23 02:06AM	Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Revised) (Zacks)
May-26-23 08:59AM	Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan (GlobeNewswire) +6.18%
May-25-23 12:25PM	Myriad Genetics (MYGN) Adds New Test to Oncology Portfolio (Zacks)
May-24-23 04:30PM	Neuronetics to Present at the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
09:34AM	Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Zacks)
May-23-23 10:10AM	Exact Sciences (EXAS) Gains From New Buyouts Amid High Costs (Zacks)
08:46AM	New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction (GlobeNewswire)
May-22-23 08:01AM	Thermo Fisher (TMO) Gets FDA Clearance for Its Immunoassays (Zacks)
May-18-23 10:16AM	Illumina (ILMN) Progresses in Pathogen Genomic Technologies (Zacks) -6.88%
May-17-23 11:09AM	Hologic (HOLX) Announces Collaboration With NFL CB Kelee Ringo (Zacks)
May-15-23 08:56AM	Neuronetics Wins 2023 Bell Seal for Workplace Mental Health (GlobeNewswire)
07:58AM	Integra (IART) Builds Advanced R&D Facility in New Jersey (Zacks)
May-09-23 05:00PM	Neuronetics to Present at the JMP Securities Life Sciences Conference (GlobeNewswire) +27.27%
08:55AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Neuronetics Reports Record First Quarter 2023 Financial and Operating Results (GlobeNewswire)
May-08-23 08:47AM	Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR (GlobeNewswire)
May-05-23 08:30AM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-03-23 08:58AM	Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting (GlobeNewswire)
May-02-23 09:01AM	NeuroStar® Expands Tap Into Possibility Campaign in Honor of Mental Health Awareness Month (GlobeNewswire)
May-01-23 08:46AM	Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer (GlobeNewswire)
Apr-28-23 04:11PM	Neuronetics Announces Expanded TMS Access through United HealthCare (GlobeNewswire)
Apr-25-23 08:30AM	Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-18-23 02:14PM	Further weakness as Neuronetics (NASDAQ:STIM) drops 11% this week, taking one-year losses to 25% (Simply Wall St.)
Apr-13-23 08:58AM	Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy (GlobeNewswire)
Apr-06-23 04:16PM	NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities (GlobeNewswire) -9.38%
Apr-04-23 08:30AM	Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note (GlobeNewswire)
Mar-16-23 08:56AM	NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA (GlobeNewswire)
Mar-08-23 10:02PM	Neuronetics, Inc. (NASDAQ:STIM) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.93%
12:44AM	Q4 2022 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 08:45AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -19.19%
07:30AM	Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results (GlobeNewswire)
Mar-02-23 04:02PM	Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives (GlobeNewswire) -5.26%
Feb-27-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-23-23 08:56AM	Neuronetics Expands NeuroStar® Advanced Therapys Proprietary TrakStar® Platform (GlobeNewswire) -10.02%
Feb-22-23 04:35PM	Neuronetics to Report Fourth Quarter 2022 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-21-23 08:53AM	Neuronetics Sponsors the 5th International Brain Stimulation Conference (GlobeNewswire)
Feb-16-23 04:12PM	Neuronetics Announces Elevation of Sara Grubbs to SVP, Chief Revenue Officer (GlobeNewswire)
Feb-10-23 04:15PM	Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners (GlobeNewswire)
Jan-19-23 10:50AM	Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS (Benzinga)
08:30AM	Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership (GlobeNewswire)
Jan-18-23 04:29PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.35%
Jan-17-23 08:32AM	Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health (GlobeNewswire)

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 29 '24	Sale	2.94	6,026	17,716	389,333	Mar 01 05:02 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 28 '24	Sale	3.16	22,377	70,711	395,359	Mar 01 05:02 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 28 '24	Sale	3.16	3,985	12,593	483,776	Feb 29 05:02 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 27 '24	Sale	3.33	21,272	70,836	487,761	Feb 29 05:02 PM
Sullivan Keith J	President and CEO	Feb 26 '24	Sale	3.30	20,292	66,964	1,372,278	Feb 28 05:02 PM
Sullivan Keith J	President and CEO	Feb 23 '24	Sale	3.23	20,750	67,022	1,392,570	Feb 26 05:21 PM
Sullivan Keith J	President and CEO	Feb 22 '24	Sale	3.23	20,851	67,349	1,413,320	Feb 26 05:21 PM
Sullivan Keith J	President and CEO	Feb 20 '24	Sale	2.96	23,958	70,916	1,434,171	Feb 22 05:02 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 14 '24	Sale	3.38	15,621	52,799	417,736	Feb 16 05:11 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 09 '24	Sale	3.51	14,710	51,632	509,033	Feb 13 06:00 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 06 '24	Sale	3.39	5,813	19,706	523,743	Feb 07 05:41 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 06 '24	Sale	3.39	5,385	18,255	433,357	Feb 07 05:42 PM
Sullivan Keith J	President and CEO	Jan 11 '24	Sale	3.16	9,516	30,071	1,158,129	Jan 12 06:00 PM
Sullivan Keith J	President and CEO	Jan 10 '24	Sale	3.01	10,013	30,139	1,167,645	Jan 12 06:00 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Dec 21 '23	Sale	2.52	11,663	29,391	348,742	Dec 21 07:42 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Dec 20 '23	Sale	2.70	11,664	31,493	360,405	Dec 21 07:42 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Dec 19 '23	Sale	2.24	11,664	26,127	372,069	Dec 21 07:42 PM
Furlong Stephen	EVP, CFO and Treasurer	Oct 06 '23	Sale	1.16	1,499	1,731	429,556	Oct 10 05:10 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Oct 06 '23	Sale	1.16	1,469	1,697	383,733	Oct 10 05:12 PM
Sullivan Keith J	President and CEO	Jul 21 '23	Sale	2.04	6,551	13,364	1,177,658	Jul 25 07:50 PM
Sullivan Keith J	President and CEO	Jul 20 '23	Sale	2.06	6,510	13,411	1,184,209	Jul 21 06:15 PM
Sullivan Keith J	President and CEO	Jul 19 '23	Sale	2.07	6,479	13,412	1,190,719	Jul 21 06:15 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Jul 11 '23	Sale	2.13	2,645	5,634	385,202	Jul 12 08:35 PM
BAKEWELL JOHN K	Director	May 24 '23	Sale	2.70	14,400	38,880	77,988	May 26 04:10 PM

Open in Screener

KRMD

KORU Medical Systems Inc

May 01 • 11:07AM ET

2.21

Dollar change +0.04
Percentage change 1.84	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

KRMD KORU Medical Systems Inc daily Stock Chart

Held by: VTI IWM VXF IWO VTWO IWC VTWG OMFS VTHR DFUS

Index	RUT	P/E	-	EPS (ttm)	-0.30	Insider Own	5.90%	Shs Outstand	45.67M	Perf Week	0.45%
Market Cap	102.92M	Forward P/E	-	EPS next Y	-0.08	Insider Trans	0.00%	Shs Float	43.83M	Perf Month	-6.75%
Income	-13.74M	PEG	-	EPS next Q	-0.04	Inst Own	56.56%	Short Float	2.62%	Perf Quarter	6.25%
Sales	28.52M	P/S	3.61	EPS this Y	-7.69%	Inst Trans	1.09%	Short Ratio	11.77	Perf Half Y	-4.74%
Book/sh	0.45	P/B	4.96	EPS next Y	44.29%	ROA	-38.82%	Short Interest	1.15M	Perf Year	-46.88%
Cash/sh	0.25	P/C	8.97	EPS next 5Y	-	ROE	-53.18%	52W Range	1.98 - 4.45	Perf YTD	-9.98%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-57.24%	52W High	-50.34%	Beta	0.55
Dividend TTM	-	Quick Ratio	3.77	Sales past 5Y	11.20%	Gross Margin	55.54%	52W Low	11.71%	ATR (14)	0.13
Dividend Ex-Date	-	Current Ratio	4.55	EPS Y/Y TTM	-56.39%	Oper. Margin	-36.01%	RSI (14)	51.20	Volatility	4.57% 6.49%
Employees	82	Debt/Eq	0.22	Sales Y/Y TTM	2.23%	Profit Margin	-48.18%	Recom	1.00	Target Price	3.70
Option/Short	Yes / Yes	LT Debt/Eq	0.18	EPS Q/Q	-275.00%	Payout	-	Rel Volume	0.35	Prev Close	2.17
Sales Surprise	3.48%	EPS Surprise	50.00%	Sales Q/Q	-2.16%	Earnings	May 01 AMC	Avg Volume	97.66K	Price	2.21
SMA20	-0.42%	SMA50	1.28%	SMA200	-6.66%	Trades		Volume	9,782	Change	1.84%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-07-23	Initiated	Lake Street	Buy	$4
Sep-07-23	Initiated	B. Riley Securities	Buy	$4.50
Nov-10-22	Upgrade	Piper Sandler	Neutral → Overweight	$3 → $3.50
Nov-10-22	Upgrade	Canaccord Genuity	Hold → Buy	$3 → $4
Jan-26-21	Downgrade	Piper Sandler	Overweight → Neutral	$9 → $4.50
Jan-26-21	Downgrade	Canaccord Genuity	Buy → Hold	$5
Aug-10-20	Initiated	H.C. Wainwright	Buy	$16
Jul-16-20	Initiated	Canaccord Genuity	Buy	$13
Jun-24-20	Initiated	Piper Sandler	Overweight	$12

Apr-17-24 07:00AM	KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 (Business Wire)
Apr-11-24 04:05PM	KORU Medical Systems Announces Successful Appeal in EU Notified Body Review (Business Wire)
Mar-18-24 05:24PM	KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference (Business Wire) -5.45%
Mar-13-24 04:05PM	KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance (Business Wire)
Mar-12-24 08:22AM	KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion (Zacks)
04:05PM	Loading…
Mar-11-24 04:05PM	KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic (Business Wire)
Mar-06-24 07:00AM	KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin (Business Wire) +5.39%
Feb-21-24 07:00AM	KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 (Business Wire)
Nov-29-23 07:00AM	KORU Medical Systems to Participate in Piper Sandlers 35th Annual Healthcare Conference (Business Wire)
Nov-28-23 08:00AM	KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023 (Business Wire)
Nov-09-23 10:04AM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.31%
Nov-08-23 06:11PM	KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year Outlook (GuruFocus.com) -5.19%
04:10PM	KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System (Business Wire)
04:08PM	KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer (Business Wire)
04:05PM	KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook (Business Wire)
04:05PM	Loading…
Nov-07-23 04:05PM	KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes (Business Wire)
Nov-02-23 04:05PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-23 04:05PM	KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023 (Business Wire)
Oct-05-23 07:05AM	KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference (Business Wire)
Oct-04-23 04:05PM	KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors (Business Wire)
Sep-15-23 08:05AM	KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase (Business Wire)
Aug-09-23 04:05PM	KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook (Business Wire)
Aug-08-23 04:05PM	KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference (Business Wire)
Aug-02-23 05:15PM	KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates (Business Wire)
Jul-31-23 04:05PM	KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023 (Business Wire)
Jul-27-23 04:05PM	KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic (Business Wire)
Jul-10-23 07:01AM	KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes (Business Wire)
Jun-27-23 07:05AM	KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer (Business Wire)
May-09-23 03:15PM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-04-23 04:01PM	KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results (Business Wire)
07:01AM	Loading…
Apr-21-23 07:01AM	KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 (Business Wire)
Mar-08-23 04:01PM	KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022 (Business Wire)
Feb-22-23 04:01PM	KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 (Business Wire)
Jan-25-23 07:01AM	KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement (Business Wire)
Nov-21-22 07:01AM	KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference (Business Wire)
Nov-10-22 04:01PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire) +16.88%
Nov-09-22 04:01PM	KORU Medical Systems Announces 2022 Third Quarter Financial Results (Business Wire)
Nov-08-22 07:01AM	KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals (Business Wire)
Oct-26-22 04:01PM	KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022 (Business Wire)
Oct-17-22 04:01PM	KORU Medical Systems to Participate in Upcoming Industry Conferences (Business Wire)
Oct-12-22 07:01AM	KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs (Business Wire)
Oct-05-22 07:01AM	KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium (Business Wire)
Aug-08-22 09:50AM	We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate (Simply Wall St.)
Aug-03-22 04:01PM	KORU Medical Systems Announces 2022 Second Quarter Financial Results (Business Wire)
Jul-20-22 04:01PM	KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022 (Business Wire)
Jul-05-22 07:08AM	Investors in Repro Med Systems (NASDAQ:KRMD) have made a fantastic return of 483% over the past five years (Simply Wall St.)
May-10-22 01:29PM	What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition (Simply Wall St.)
May-04-22 04:01PM	KORU Medical Systems Announces 2022 First Quarter Financial Results (Business Wire) +6.87%
May-02-22 04:01PM	KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge® (Business Wire)
Apr-20-22 04:01PM	KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022 (Business Wire)
Apr-18-22 05:00PM	KORU Medical Systems Appoints Brian Case As Chief Technology Officer (Business Wire)
Mar-28-22 04:47PM	Repro Med Systems, Inc. (NASDAQ:KRMD) drops to US$125m and insiders who purchased earlier this year lose another US$38k (Simply Wall St.)
Mar-02-22 04:01PM	KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results (Business Wire)
Feb-23-22 03:00PM	Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-22-22 12:30AM	CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022 (Business Wire)
Jan-26-22 07:02AM	Those who invested in Repro Med Systems (NASDAQ:KRMD) five years ago are up 523% (Simply Wall St.) +5.11%
Dec-21-21 04:01PM	KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs (Business Wire)
Dec-01-21 04:01PM	KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day (Business Wire)
Nov-27-21 08:06AM	What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition (Simply Wall St.)
Nov-10-21 04:00PM	KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes (Business Wire)
Nov-09-21 07:00AM	KORU Medical Systems to Participate in Two Upcoming Conferences (Business Wire) -6.04%
Nov-08-21 07:00AM	KORU Medical Announces Collaboration With Gilero to Accelerate Innovation (Business Wire)
Nov-01-21 07:00AM	KORU Medical Expands Senior Team to Accelerate Growth Strategy (Business Wire) +13.25%
Oct-27-21 04:01PM	KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021 (Business Wire)
Oct-26-21 03:02PM	Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline (Zacks)
07:00AM	KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs (Business Wire)
Sep-28-21 09:22AM	Multiple insiders bought Repro Med Systems, Inc. (NASDAQ:KRMD) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Aug-14-21 03:38AM	Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report (Simply Wall St.)
Aug-11-21 04:01PM	KORU Medical Systems Announces 2021 Second Quarter Financial Results (Business Wire)
Aug-09-21 07:00AM	KORU Medical Systems to Participate in Canaccord Genuitys 41st Annual Growth Conference (Business Wire)
Jul-28-21 07:00AM	KORU Medical Systems to Report Second Quarter 2021 Financial Results on August 11, 2021 (Business Wire)
Jul-27-21 03:03PM	Earnings Preview: Repro Med Systems, Inc. (KRMD) Q2 Earnings Expected to Decline (Zacks)
Jul-14-21 04:43AM	Announcing: Repro Med Systems (NASDAQ:KRMD) Stock Soared An Exciting 635% In The Last Five Years (Simply Wall St.)
Jun-28-21 01:05PM	Lifshitz Law Firm, P.C. Announces Investigations of, CleanSpark, Inc. (NasdaqGS: CLSK), The Geo Group, Inc. (NYSE: GEO), Repro Med Systems, Inc. (NasdaqGS: KRMD), and Romeo Power, Inc. (NYSE: RMO) (GlobeNewswire)
May-25-21 02:39PM	KRMD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 25, 2021 in the Class Action Filed on Behalf of Repro Med Systems, Inc. Limited Shareholders (Newsfile)
01:10PM	FINAL DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses to Contact the Firm (ACCESSWIRE)
12:37PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Repro Med Systems, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 25, 2021 - KRMD (Newsfile)
11:00AM	Last Chance to Actively Participate Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC (ACCESSWIRE)
10:49AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (Newsfile)
10:15AM	Lawsuits Filed Against KRMD, ARRY and WISH - Jakubowitz Law Pursues Shareholders Claims (ACCESSWIRE)
09:05AM	KRMD FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Repro Med Systems, Inc. Investors to Secure Counsel Before Important May 25 Deadline KRMD (GlobeNewswire)
08:00AM	Repro-Med Systems, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm (GlobeNewswire)
05:55AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KRMD, FGEN and CCXI (ACCESSWIRE)
01:45AM	SHAREHODLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Repro Med Systems, Inc. d/b/a KORU Medical Systems of Class Action Lawsuit and Upcoming Deadline - KRMD (PR Newswire)
12:40AM	FINAL DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in to Contact the Firm (ACCESSWIRE)
May-24-21 03:20PM	CLASS ACTION UPDATE for KRMD, ACAD and CCIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders (ACCESSWIRE)
12:30PM	FINAL DEADLINE TUESDAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in to Contact the Firm (ACCESSWIRE)
11:30AM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD) (Business Wire)
10:48AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (Newsfile)
10:00AM	Two Days Left to Actively Participate in Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC (Newsfile)
07:10AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KRMD, RMO and CCXI (ACCESSWIRE)
06:25AM	LAWSUITS FILED AGAINST KRMD, PCT and DNMR - Jakubowitz Law Pursues Shareholders Claims (ACCESSWIRE)
May-22-21 11:16PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Repro Med Systems, Inc. d/b/a KORU Medical Systems of Class Action Lawsuit and Upcoming Deadline - KRMD (Newsfile)
May-21-21 02:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KRMD, DOX and EBS (ACCESSWIRE)
12:30PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (ACCESSWIRE)
11:10AM	SHAREHOLDER ALERT: KRMD DDD CCXI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines (ACCESSWIRE)
11:00AM	Last Couple of Days to Actively Participate Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC (ACCESSWIRE)
11:00AM	DEADLINE ALERT for KRMD, SOS, GOEV, EBON: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders (GlobeNewswire)
10:41AM	TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (Newsfile)
May-20-21 05:05PM	Lawsuits Filed Against KRMD, DDD and UI - Jakubowitz Law Pursues Shareholders Claims (ACCESSWIRE)

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Manko Joseph M. Jr.	Director	Dec 13 '23	Buy	2.40	145,833	349,999	7,609,751	Dec 15 04:05 PM
Manko Joseph M. Jr.	Director	Dec 13 '23	Sale	2.40	145,833	349,999	2,198,825	Dec 15 04:05 PM
Manko Joseph M. Jr.	Director	Aug 21 '23	Buy	2.65	10,000	26,466	7,458,434	Aug 22 04:58 PM
Manko Joseph M. Jr.	Director	Aug 18 '23	Buy	2.54	10,000	25,407	7,448,434	Aug 22 04:58 PM
Tharby Linda M	President and CEO	Aug 18 '23	Buy	2.53	5,272	13,336	1,056,676	Aug 24 09:17 AM
CASCELLA ROBERT	Director	Aug 16 '23	Buy	2.61	19,000	49,533	41,478	Aug 17 04:13 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

STIM

Neuronetics Inc

KRMD

KORU Medical Systems Inc

Upgrade your FINVIZ experience